Literature DB >> 31097106

Benign and Premalignant Lesions of the Endometrium.

Wesley Daniel Mallinger1, Charles Matthew Quick2.   

Abstract

In this review, we highlight the benign and premalignant lesions of the endometrium that the pathologist may encounter in daily practice. We begin by detailing our current understanding of excess estrogen in the progression of endometrial neoplasia. We outline the currently accepted terminology to be used when evaluating proliferative endometrial lesions, while highlighting their key features. Attention is then turned to the molecular underpinnings of neoplastic progression and how this can be exploited with immunohistochemical stains when appropriate. Finally, we discuss types of metaplasia and their associations, including so-called papillary proliferations of the endometrium.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical hyperplasia; Benign hyperplasia; EIN; Endometrial metaplasia; Papillary proliferations

Mesh:

Substances:

Year:  2019        PMID: 31097106     DOI: 10.1016/j.path.2019.01.003

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  3 in total

1.  TWIST1 expression and clinical significance in type I endometrial cancer and premalignant lesions: A retrospective clinical study.

Authors:  Junhua Shen; Qin Chen; Na Li; Xiaoxia Bai; Fenfen Wang; Baohua Li
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

2.  The Value of Vaginal Microbiome in Patients with Endometrial Hyperplasia.

Authors:  Hu Zhang; Qiao Feng; Zhanpeng Zhu; Haiyan Dai; Hua Hu
Journal:  J Healthc Eng       Date:  2021-12-18       Impact factor: 2.682

3.  Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947-1964: The Nurses' Health Study II, a prospective cohort study.

Authors:  Norah A Burchardt; Amy L Shafrir; Rudolf Kaaks; Shelley S Tworoger; Renée T Fortner
Journal:  Eur J Epidemiol       Date:  2020-12-17       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.